@dansfera: The harsh truth about pharma investing just got laid bare! 🤯 Forget chasing those incremental me too products. With the current market pushing for true innovation, the real winners in biotech are those aiming for *first-and-only* or *best-in-class* potential. If a drug doesn't fundamentally change the established standard of care in the US, the sales struggle is real, even post-approval. This is a crucial lens through which to view the entire drug pipeline! \#PharmaStocks \#BiotechInvesting \#StockMarketTips \#InvestmentStrategy \#WallStreet